Last reviewed · How we verify

NCT07264946

Talocrural Manipulation and Ankle Muscle Architecture

Completed NA Last updated 3 April 2026
What this trial tests

NA trial testing Placebo Talocrural Joint Manipulation in Stroke in 36 participants. Completed in 15 November 2025.

Timeline
10 October 2025
Primary endpoint
15 November 2025
15 November 2025

Quick facts

Lead sponsorBitlis Eren University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designcrossover
Maskingdouble
Primary purposetreatment
Enrollment36
Start date10 October 2025
Primary completion15 November 2025
Estimated completion15 November 2025
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Bitlis Eren University

Who can join

Adults 45 to 75, any sex, with Stroke. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this study is to investigate the effect of talocrural joint manipulation on the ankle muscle architecture in patients with stroke. This study was registered retrospectively due to the U.S. government shutdown (October 1 to November 12, 2025), which prevented timely registration despite prior intent to register prospectively.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Talocrural Joint Manipulation

Trials testing the same drug.

Other recruiting trials for Stroke

Currently open trials in the same condition.

Other Bitlis Eren University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07264946.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing